Sodium-glucose cotransporter-2 (SGLT2) inhibitors have rapidly reshaped the management of kidney and cardiovascular disease. Initially developed as...
When initiated shortly after an acute myocardial infarction, empagliflozin (Jardiance; Boehringer Ingelheim, Eli Lilly) not only...
